div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imageimg data-url=-30-and-10-of-patients-respectively-and-occur-early-in-carcinogenesis-althoughhtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: biocanrxcom30% and 10% of patients respectively and occur early in carcinogenesis Although researchers have not found ways to target mutated KRAS with cancer drugs recent loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader036vdocumentsnetreader036viewer202208161660013320c19deb1982462c03html5thumbnails1jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imageimg data-url=-30-and-10-of-patients-respectively-and-occur-early-in-carcinogenesis-althoughhtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: biocanrxcom30% and 10% of patients respectively and occur early in carcinogenesis Although researchers have not found ways to target mutated KRAS with cancer drugs recent loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader036vdocumentsnetreader036viewer202208161660013320c19deb1982462c03html5thumbnails2jpg width=140 height=200 divdiv
